Targeted Oncology
Treating Together
Targeted Oncology brings you Treating Together , a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.
Be sure to visit the podcast's website and support the creator: www.targetedonc.com
Author
Targeted Oncology
Category
Podcast website
Latest episode
Nov 17, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers 15.02.2023 17:36
In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment 17.11.2022 21:04
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment 17.11.2022 21:04
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.
S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer 25.10.2022 17:45
In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.
S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting 16.09.2022 17:24
In season 3, episode 8 of Targeted Talks, Christie J. Hilton, DO, discusses treating first- and second-line HER2-positive breast cancer.
S3 Ep7: The Evolution of Endometrial Cancer Treatment 15.08.2022 9:36
In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.
S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm 15.07.2022 12:36
Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment 15.06.2022 8:47
In season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.
S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia 17.05.2022 10:37
In season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.
S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer Management 15.04.2022 13:16
In season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guidelines for managing early-stage breast cancer.
S3 Ep2: Advances and Pending Innovations in the Treatment of Sarcoma 16.03.2022 18:39
Mark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.
S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma 15.02.2022 9:24
In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.
S2 Ep10: Treating Sarcoma With a Multidisciplinary Approach 15.12.2021 16:37
Sandra P. D'Angelo, MD and Katherine Poruk, MD
S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer 17.11.2021 17:57
In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.
S2 Ep8: New Targeted Therapies in Renal Cell Carcinoma 15.09.2021 41:27
In season 2, episode 8 of “Targeted Talks,” Thomas Hutson, DO, PharmD, and Rana R. McKay, MD, of UC San Diego Health, discussed the renal cell carcinoma paradigm and challenges to overcome in the future.
S2 Ep7: Recent Developments in Immunotherapy for Melanoma 16.08.2021 24:02
In season 2, episode 8 of Targeted Talks, Jeff Yorio, MD, and Douglas Johnson, MD, MSCI, joins us for a talk around recent advances in immunotherapy for melanoma.
S2 Ep6: Special Episode: Insight on Targeting Rare Genomic Alterations in Colorectal Cancer 15.07.2021 16:06
In season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman joins us for a special discussion around rare genomic alterations in colorectal cancer.
S2 Ep5: Advancing the Treatment of Cervical and Endometrial Cancers 15.06.2021 33:25
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
S2 Ep4: Special Episode: Oncology After COVID-19 14.05.2021 9:00
In season 2, episode 4 of Targeted Talks, Benjamin O. Anderson, MD, FACS, discussed the lessons learned from the COVID-19 pandemic, and preparation for a post-COVID America.
S2 Ep3: Modern Strategies Improving Immunotherapy in Cancer 15.04.2021 29:27
Jason Luke, MD, leads a discussion with Sandip Patel, MD, about the present and future of immunotherapy in cancer.
S2 Ep2: The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer 15.02.2021 32:45
Cathy Eng, MD and Benjamin Weinberg, MD discuss the gut microbiome and how it impacts young patients with colorectal. They also discuss the potential to use gut microbiome test to inform diagnosis, treatment, and monitoring of patients.
S2 Ep1: Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer 15.01.2021 28:27
Nagashree Seetharamu, MD and with Luis E. Raez, MD discuss the evolving treatment landscape of EGFR exon 20–mutated lung cancer.
S1 Ep5: COVID-19 Leaves Its Mark on Oncology Care 17.12.2020 26:12
Debra Patt, MD, PhD, MBA, speaks with Alex Spira, MD, PhD, FACP, about the impact of the COVID-19 pandemic on community cancer centers and hospitals in the United States
S1 Ep4: Prostate Cancer Sees Surge of PARP Inhibition Strategies 15.10.2020 24:08
In season 1, episode 4 of Targeted Talks, Michael Schweizer, MD, associate professor. Clinical Research Division, Fred Hutchinson Cancer Research Center, spoke with fellow oncologist, Winston Tan, MD, medical oncologist and professor of medicine, Mayo Clinic, about the ever-changing treatment landscape for prostate cancer.
S1 Ep3: Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss 25.09.2020 28:18
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion with Stephanie Graff, MD, and Gabriel N. Hortobagyi, MD, FACP.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.